article thumbnail

£7M financing to drive commercialisation in cell and gene therapy 

Drug Discovery World

Using MIPs’ sophisticated and highly scalable synthetic chemistry approach means they are well positioned to benefit from this tremendous high growth opportunity.” Liz Klein, Investment Director at Calculus, added: “MIP Discovery’s synthetic affinity reagents hold huge potential to overcome bottlenecks in CGT development and production.

Therapies 130
article thumbnail

Eco-friendly enzyme to create key chemical building blocks

Science Daily: Pharmacology News

Applying this photoenzymatic approach, researchers have developed a clean, efficient way to synthesize crucial chemical building blocks known as chiral amines, solving a longstanding challenge in synthetic chemistry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Transforming high-throughput screening with mass spectrometry

Drug Discovery World

Keeping pace with synthetic chemistry HTE in support of drug molecule design . Another emerging application area of timsTOF technology in the pharmaceutical industry is synthetic chemistry HTE, which involves developing large libraries of newly designed molecules by running large numbers of chemical reactions in parallel.

article thumbnail

Tackling pain and mental health with plant-based medicines

Drug Discovery World

This was first demonstrated in 1899 with the production of aspirin, a semi-synthetic drug based on the natural product salicin isolated from white bark (Salix alba).

article thumbnail

Drug Discovery and Medicinal Chemistry in the Era of Automation - Webinar Recap

The Strateos Blog: Drug Discovery

Director of Chemistry of Strateos gave an interactive talk focused on how automated robotics and integrated software are powering self-driving labs that are revolutionizing synthetic chemistry to support medicinal chemistry workflows. Director of R&D Strategy and Vince Yeh, Ph.D.,

article thumbnail

Part 2 Chemistry Webinar Series: Remote Access Robotic Controlled Compound Synthesis - Recap

The Strateos Blog: Drug Discovery

On September 15th, Strateos hosted Part 2 of its Chemistry Webinar Series: Remote Access Robotic Controlled Compound Synthesis. Ben Miles, Ph.D., Head of Product Management at Strateos was joined by Josh Bond, Director of Product Management at PerkinElmer Informatics to discuss this exciting collaboration.

article thumbnail

Women in Stem with Dr Mrunal Jaywant

Drug Target Review

At USP India, Dr Jaywant oversees the Compendial Development, the Synthetic Chemistry, and the Analytical Research and Development Laboratories. About the author Dr Mrunal Jaywant Vice President of R&D at USP India Dr Jaywant has been with USP for seven years and has more than 27 years of experience in the pharmaceutical industry.